Fmoc-3-氨基-3-（4-甲氧基苯基）-丙酸

Fmoc-3-amino-3-(4-methoxyphenyl)-propionic acid

Ethyl 3-(4-chlorophenyl)-1,2,4-thiadiazole-5-carboxylate, 98%

3-(4-Chlorophenyl)-[1,2,4]thiadiazole-5-carboxylic acid ethyl ester

2-溴-3-甲基丁酸乙酯

Ethyl 2-bromo-3-methylbutyrate

试剂级

7-甲基-2-哌啶-4-基-1H-苯并咪唑

7-Methyl-2-piperidin-4-yl-1H-benzimidazole

Methyl 6-tert-butoxycarbonylamino-2-pyridinecarboxylate, 98%

Methyl 6-(_{[(2-methyl-2-propanyl)oxy]carbonyl}amino)-2-pyridinecarboxylate

2-[(二甲氨基)甲基]苯酚

2-[(Dimethylamino)methyl]phenol

试剂级

7-甲氧基-1-甲基-1,2,3,4-四氢异喹啉-6-醇盐酸盐水合物

7-Methoxy-1-methyl-1,2,3,4-tetrahydro-isoquinolin-6-ol hydrochloride hydrate

N-(3-cyano-1-pentyl-1H-pyrrolo[2,3-b]quinoxalin-2-yl)-4-fluorobenzamide, >99%

N-(3-cyano-1-pentyl-1H-pyrrolo[2,3-b]quinoxalin-2-yl)-4-fluorobenzamide

3-(二氟甲氧基)苯乙炔

3-(difluoromethoxy)phenylacetylene

试剂级

1-（3-氯-4-甲氧基-苯基）-吡咯-2,5-二酮

1-(3-Chloro-4-methoxy-phenyl)-pyrrole-2,5-dione

1-[1-(Trifluoroacetyl)-4-piperidinyl]-3-[4-(trifluoromethoxy)phenyl]urea, 98%

1-[1-(Trifluoroacetyl)-4-piperidinyl]-3-[4-(trifluoromethoxy)phenyl]urea

斯巴他利单抗（抗PD-1）

Spartalizumab (anti-PD-1)

99%

O-乙基 S-((6-三氟甲基)吡啶-3-基)甲基)二硫代碳酸酯, 98%

O-Ethyl S-((6-(trifluoromethyl)pyridin-3-yl)methyl) carbonodithioate

5-乙基-4-硝基-1H-吡唑-3-羧酰胺

5-ethyl-4-nitro-1H-pyrazole-3-carboxamide

[1,2-二苯基-1,2-二(4-羧基苯基]乙烯, 99%

4,4'-(1,2-Diphenylethene-1,2-diyl)dibenzoic acid

Fmoc-3-氨基-2-萘甲酸

2-Naphthalenecarboxylicacid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-

96%

2,6-二氯苯甲醚, ＞99%

2,6-Dichloroanisole

2-叔丁基-1H-苯并咪唑-5-基胺

2-tert-Butyl-1H-benzoimidazol-5-ylamine

4-{[4-（溴甲基）苯基]磺酰基}吗啉

4-{[4-(Bromomethyl)phenyl]sulphonyl}morpholine

99%

Nα-Fmoc-Nepsilon-生物素-ε-氨基己酰基-L-赖氨酸

Nα-Fmoc-Nepsilon-biotinyl-epsilon-aminocaproyl-L-lysine